Beatriz Cuevas

14PUBLICATIONS
86CO-AUTHORS
Haematological tumoursHaematologyGene and molecular therapyMolecular targetsRespiratory diseases
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (14)

|Aug 04, 2026
Survival outcomes and treatment patterns in myelofibrosis in the JAK inhibitor era.

|Jul 13, 2026
Mutational profile and cardiovascular risk factors impact prognosis in triple-negative essential thrombocythemia.

|May 04, 2026
Impact of CYP and ABCB1 Polymorphisms on Bortezomib-Induced Adverse Events in Multiple Myeloma.

|Oct 17, 2025
Coexisting Myeloproliferative and Lymphoid Neoplasms: A European Multicenter Retrospective Study.

Dolly Viviana Fiallo-Suárez, Ruth Stuckey, Cristina Bilbao-Sieyro

|Sep 28, 2024
Prognostic value of response to first-line hydroxyurea according to IPSET stratification in essential thrombocythemia.

Marta Santaliestra, Marta Garrote, María Soledad Noya

|Apr 28, 2023
Bortezomib Pharmacogenetic Biomarkers for the Treatment of Multiple Myeloma: Review and Future Perspectives.

Antonio Sanz-Solas, Jorge Labrador, Raquel Alcaraz

Pageof 3

Frequent Collaborators

12 joint publications

Juan-Carlos Hernández-Boluda

8 joint publications

Gonzalo Carreno-Tarragona

8 joint publications

Valentin Garcia-Gutierrez

7 joint publications

Francisca Ferrer-Marín